Antitumour bioactive peptides isolated from marine organisms
Authors:
Open Access
- 4 July 2017
- journal article
- review article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 44 (11) , 1077-1082
Abstract
Summary: Marine organisms are an important source of antitumour active substances. Thus, pharmaceutical research in recent years has focused on exploring new antitumour drugs derived from marine organisms, and, many peptide drugs with strong antitumour activities have been successfully extracted. Based on different mechanisms, this paper reviews the research on several typical antitumour bioactive peptides in marine drugs and the latest progress therein. Additionally, the development prospects for these antitumour bioactive peptide‐based drugs are discussed so as to provide a reference for future research in this field.Keywords
Funding Information
- National Natural Science Foundation of China (81573003)
This publication has 45 references indexed in Scilit:
- Chlorinated Didemnins from the Tunicate Trididemnum solidumMarine Drugs, 2013
- Predictive Factors of Sensitivity to Elisidepsin, a Novel Kahalalide F-Derived Marine CompoundMarine Drugs, 2013
- Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphomaHaematologica, 2012
- In vitro and in vivo evaluation of select kahalalide F analogs with antitumor and antifungal activitiesBioorganic & Medicinal Chemistry, 2011
- Systematic Chemical Mutagenesis Identifies a Potent Novel Apratoxin A/E Hybrid with Improved in Vivo Antitumor ActivityACS Medicinal Chemistry Letters, 2011
- Antineoplastic Agents. 592. Highly Effective Cancer Cell Growth Inhibitory Structural Modifications of Dolastatin 10Journal of Natural Products, 2011
- Chemoradiotherapy With or Without AE-941 in Stage III Non–Small Cell Lung Cancer: A Randomized Phase III TrialJNCI: Journal of the National Cancer Institute, 2010
- Two New Jaspamide Derivatives from the Marine Sponge Jaspis splendensMarine Drugs, 2009
- Cyclodepsipeptide toxin promotes the degradation of Hsp90 client proteins through chaperone-mediated autophagyJournal of Cell Biology, 2009
- Phase II study of weekly Kahalalide F in patients with advanced malignant melanomaEuropean Journal of Cancer, 2009